Chan C; Vaccher S; Fraser D; Grulich AE; Holt M; Zablotska-Manos I; Prestage GP; Bavinton BR, 2022, 'Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia', AIDS and Behavior, vol. 26, pp. 88 - 95, http://dx.doi.org/10.1007/s10461-021-03344-3

Hammoud MA; Grulich A; Holt M; Maher L; Murphy D; Jin F; Bavinton B; Haire B; Ellard J; Vaccher S; Saxton P; Bourne A; Degenhardt L; Storer D; Prestage G, 2021, 'Substantial decline in use of HIV pre-exposure prophylaxis (PrEP) following introduction of COVID-19 physical distancing restrictions in Australia: Results from a prospective observational study of gay and bisexual men.', J Acquir Immune Defic Syndr, vol. Publish Ahead of Print, http://dx.doi.org/10.1097/QAI.0000000000002514

Drak D; Mcmanus H; Vickers T; Heron JE; Vaccher S; Zablotska I; Guy R; Bavinton B; Jin F; Grulich AE; Bloch M; O'Connor CC; Gracey DM, 2021, 'Renal impairment in a large-scale HIV preexposure prophylaxis implementation cohort', AIDS (London, England), vol. 35, pp. 2319 - 2326, http://dx.doi.org/10.1097/QAD.0000000000003035

Grulich AE; Jin F; Bavinton BR; Yeung B; Hammoud MA; Amin J; Cabrera G; Clackett S; Ogilvie E; Vaccher S; Vickers T; McNulty A; Smith DJ; Dharan NJ; Selvey C; Power C; Price K; Zablotska I; Baker DA; Bloch M; Brown K; Carmody CJ; Carr A; Chanisheff D; Doong N; Finlayson R; Lewis DA; Lusk J; Martin S; Ooi C; Read P; Ryder N; Smith D; Tuck Meng Soo C; Templeton DJ; Vlahakis E; Guy R, 2021, 'Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study', The Lancet HIV, vol. 8, pp. e486 - e494, http://dx.doi.org/10.1016/S2352-3018(21)00074-6

Bavinton BR; Vaccher S; Jin F; Prestage GP; Holt M; Zablotska-Manos IB; Guy R; Amin J; Templeton DJ; Yeung B; Hammoud MA; Lewis D; Baker D; Dharan N; McNulty AM; Grulich AE, 2021, 'High Levels of Prevention-Effective Adherence to HIV PrEP: An Analysis of Substudy Data From the EPIC-NSW Trial', Journal of acquired immune deficiency syndromes (1999), vol. 87, pp. 1040 - 1047, http://dx.doi.org/10.1097/QAI.0000000000002691

Chan C; Fraser D; Vaccher S; Yeung B; Jin F; Amin J; Dharan NJ; Carr A; Ooi C; Vaughan M; Holden J; Power C; Grulich AE; Bavinton BR, 2021, 'Overcoming barriers to HIV pre-exposure prophylaxis (PrEP) coverage in Australia among Medicare-ineligible people at risk of HIV: Results from the MI-EPIC clinical trial', Sexual Health, vol. 18, pp. 453 - 459, http://dx.doi.org/10.1071/SH21096

Jin F; Amin J; Guy R; Vaccher S; Selvey C; Zablotska I; Holden J; Price K; Yeung B; Ogilvie E; Quichua GC; Clackett S; McNulty A; Smith D; Templeton DJ; Bavinton B; Grulich AE, 2021, 'Adherence to daily HIV pre-exposure prophylaxis in a large-scale implementation study in New South Wales, Australia', AIDS (London, England), vol. 35, pp. 1987 - 1996, http://dx.doi.org/10.1097/QAD.0000000000002970

Haire B; Murphy D; Maher L; Zablotska-Manos I; Vaccher S; Kaldor J, 2021, 'What does PrEP mean for 'safe sex' norms? A qualitative study', PLoS ONE, vol. 16, pp. e0255731, http://dx.doi.org/10.1371/journal.pone.0255731

Smaghi BS; Collins J; Dagina R; Hiawalyer G; Vaccher S; Flint J; Housen T, 2021, 'Barriers and enablers experienced by health care workers in swabbing for COVID-19 in Papua New Guinea: A multi-methods cross-sectional study', International Journal of Infectious Diseases, vol. 110, pp. S17 - S24, http://dx.doi.org/10.1016/j.ijid.2021.04.077

Hammoud MA; Jin F; Maher L; Bourne A; Haire B; Saxton P; Vaccher S; Lea T; Degenhardt L; Prestage G, 2020, 'Biomedical HIV Protection Among Gay and Bisexual Men Who Use Crystal Methamphetamine', AIDS and Behavior, vol. 24, pp. 1400 - 1413, http://dx.doi.org/10.1007/s10461-019-02739-7

Vaccher SJ; Hammoud MA; Bourne A; Lea T; Haire BG; Holt M; Saxton P; Mackie B; Badge J; Jin F; Maher L; Prestage G, 2020, 'Prevalence, frequency, and motivations for alkyl nitrite use among gay, bisexual and other men who have sex with men in Australia', International Journal of Drug Policy, vol. 76, pp. 102659 - 102659, http://dx.doi.org/10.1016/j.drugpo.2019.102659

Hammoud MA; Maher L; Holt M; Degenhardt L; Jin J; Murphy D; Bavinton B; Grulich A; Lea T; Haire B; Bourne A; Saxton P; Vaccher S; Ellard J; Mackie B; Batrouney C; Bath N; Prestage G, 2020, 'Physical distancing due to COVID-19 disrupts sexual behaviours among gay and bisexual men in Australia', JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. Publish Ahead of Print, http://dx.doi.org/10.1097/qai.0000000000002462

Mcmanus H; Grulich AE; Amin J; Selvey C; Vickers T; Bavinton B; Zablotska I; Vaccher S; Jin F; Holden J; Price K; Yeung B; Cabrera Quichua G; Ogilvie E; Mcnulty A; Smith D; Guy R, 2020, 'Comparison of Trends in Rates of Sexually Transmitted Infections before vs after Initiation of HIV Preexposure Prophylaxis among Men Who Have Sex with Men', JAMA Network Open, vol. 3, pp. e2030806, http://dx.doi.org/10.1001/jamanetworkopen.2020.30806

Keen P; Hammoud MA; Bourne A; Bavinton B; Holt M; Vaccher S; Haire B; Saxton P; Jin F; Maher L; Grulich AE; Prestage G, 2020, 'Use of HIV pre-exposure prophylaxis (PrEP) associated with lower HIV anxiety among gay and bisexual men in Australia who are at high risk of HIV infection', JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 83, pp. 119 - 125, http://dx.doi.org/10.1097/qai.0000000000002232

Zablotska IB; Vaccher SJ; Bloch M; Carr A; Foster R; Grulich AE; Guy R; McNulty A; Ooi C; Pell C; Poynten IM; Prestage G; Ryder N; Templeton D; Cheung C; Gianacas C; Holt M; Kaldor J; Mackie B; Mayer K; McAllister J; Murphy D; de Wit J; Wright E, 2019, 'High Adherence to HIV Pre-exposure Prophylaxis and No HIV Seroconversions Despite High Levels of Risk Behaviour and STIs: The Australian Demonstration Study PrELUDE', AIDS and Behavior, vol. 23, pp. 1780 - 1789, http://dx.doi.org/10.1007/s10461-018-2290-3

Prestage G; Maher L; Grulich A; Bourne A; Hammoud M; Vaccher S; Bavinton B; Holt M; Jin F, 2019, 'Brief Report: Changes in Behavior after PrEP Initiation among Australian Gay and Bisexual Men', Journal of Acquired Immune Deficiency Syndromes, vol. 81, pp. 52 - 56, http://dx.doi.org/10.1097/QAI.0000000000001976

Hammoud MA; Vaccher S; Jin F; Bourne A; Maher L; Holt M; Bavinton BR; Haire B; Degenhardt L; Grulich A; Prestage GP, 2019, 'HIV pre-exposure prophylaxis (PrEP) uptake among gay and bisexual men in Australia and factors associated with the non-use of PrEP among eligible men', JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 81, pp. 1 - 1, http://dx.doi.org/10.1097/qai.0000000000002047

Vaccher SJ; Marzinke MA; Templeton DJ; Haire BG; Ryder N; McNulty A; Foster R; Grulich AE; Zablotska IB; Bloch M; Carr A; Cheung C; Gianacas C; Guy R; Holt M; Kaldor J; Mackie B; Mayer K; McAllister J; Murphy D; Ooi C; Pell C; Poynten IM; Prestage G; de Wit J; Wright E; Callander D; Cooper D; Crooks L; Duck T; Holden J; Keen P; Kelleher A; Mitchell J; Price K; Selvey C; Schmidt HM; Telfer B; Whittaker B; Wilson D, 2019, 'Predictors of Daily Adherence to HIV Pre-exposure Prophylaxis in Gay/Bisexual Men in the PRELUDE Demonstration Project', AIDS and Behavior, vol. 23, pp. 1287 - 1296, http://dx.doi.org/10.1007/s10461-018-2353-5

Keen P; Jamil M; Callander D; Conway DP; McNulty A; Davies SC; Couldwell DC; Smith DE; Holt M; Vaccher SJ; Gray J; Cunningham P; Prestage G; Guy R, 2019, 'Rapid HIV testing increases testing frequency among gay and bisexual men: a controlled before–after study', Sexual Health, vol. 16, http://dx.doi.org/10.1071/sh18161

Jin F; Hammoud MA; Maher L; Degenhardt L; Bourne A; Lea T; Vaccher S; Grierson J; Haire BG; Prestage G, 2018, 'Age related prevalence and age related incidence of illicit drug use in a cohort of Australian gay and bisexual men: Results form the FLUX study', Drug and Alcohol Dependence, vol. 188, pp. 175 - 179, http://dx.doi.org/10.1016/j.drugalcdep.2018.04.009

Hammoud MA; Vaccher S; Jin F; Bourne A; Haire BG; Maher L; Lea T; Prestage G, 2018, 'The new MTV generation: Using methamphetamine, Truvada and Viagra to enhance sex and stay safe.', International Journal of Drug Policy, vol. 55, pp. 197 - 204, http://dx.doi.org/10.1016/j.drugpo.2018.02.021

Grulich AE; Guy R; Amin J; Jin F; Selvey C; Holden J; Schmidt HMA; Zablotska I; Price K; Whittaker B; Chant K; Cooper C; McGill S; Telfer B; Yeung B; Levitt G; Ogilvie EE; Dharan NJ; Hammoud MA; Vaccher S; Watchirs-Smith L; McNulty A; Smith DJ; Allen DM; Baker D; Bloch M; Bopage RI; Brown K; Carr A; Carmody CJ; Collins KL; Finlayson R; Foster R; Jackson EY; Lewis DA; Lusk J; O'Connor CC; Ryder N; Vlahakis E; Read P; Cooper DA; Smith D; Ooi C; Martin S; Soo TM; Templeton D; Townson D; Forssman B; Doong N; Han Thai G; Anderson B; MacLeod H; Parkhill N, 2018, 'Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study', The Lancet HIV, vol. 5, pp. e629 - e637, http://dx.doi.org/10.1016/S2352-3018(18)30215-7

Zablotska IB; Selvey C; Guy R; Price K; Holden J; Schmidt HM; McNulty A; Smith D; Jin F; Amin J; Cooper DA; Grulich AE; Parkhill N; Chant K; Cooper C; Crooks L; Allen D; Baker D; Bloch M; Bopage R; Brown K; Carr A; Carmody C; Collins K; Finlayson R; Foster R; Jackson E; Lewis D; Lusk J; O'Connor C; Ryder N; Vlahakis E; Read P; Yeung B; Levitt G; Ogilvie E; Vaccher S; Hammoud M; Watchirs-Smith L; Wabe N, 2018, 'Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): Design of an open label, single arm implementation trial', BMC Public Health, vol. 18, http://dx.doi.org/10.1186/s12889-017-5018-9

Vaccher SJ; Kaldor JM; Callander D; Zablotska IB; Haire BG, 2018, 'Qualitative Insights into Adherence to HIV Pre-Exposure Prophylaxis (PrEP) among Australian Gay and Bisexual Men', AIDS Patient Care and STDs, vol. 32, pp. 519 - 528, http://dx.doi.org/10.1089/apc.2018.0106

Vaccher SJ; Gianacas C; Templeton DJ; Poynten IM; Haire BG; Ooi C; Foster R; McNulty A; Grulich AE; Zablotska IB, 2017, 'Baseline preferences for daily, event-driven, or periodic hiv pre-exposure prophylaxis among gay and bisexual men in the prelude demonstration project', Frontiers in Public Health, vol. 5, http://dx.doi.org/10.3389/fpubh.2017.00341

Vaccher SJ; Grulich AE; Haire B; Conway D; Poynten M; Ooi C; Foster R; Templeton D; Zablotska-Manos I, 2017, 'Validation of participant eligibility for pre-exposure prophylaxis: Baseline data from the PRELUDE Demonstration Project', PLoS One, vol. 12, pp. e0185398, http://dx.doi.org/10.1371/journal.pone.0185398

Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I; Carr A; Cheung C; Foster R; Gianacas C; Guy R; Holt M; Kaldor J; Mackie B; Mayer K; Murphy D; Ooi C; Pell C; Poynten M; Ryder N; De Wit J; Wright E, 2016, 'Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE', BMJ Open, vol. 6, http://dx.doi.org/10.1136/bmjopen-2016-012179

Vaccher S; Kannangara DRW; Baysari MT; Reath J; Zwar N; Williams KM; Day RO, 2016, 'Barriers to care in gout: From prescriber to patient', Journal of Rheumatology, vol. 43, pp. 144 - 149, http://dx.doi.org/10.3899/jrheum.150607

Zablotska I; Vaccher S; Gianacas C; Prestage G; McNulty A; Holden J; Schmidt H; Templeton DJ; Poynten IM; Grulich A, 2015, 'LB1.4 Sti rates among gay men taking daily antiretrovirals for pre-exposure prophylaxis of hiv: the nsw demonstration project prelude', Sexually Transmitted Infections, vol. 91, pp. A78.2 - A78, http://dx.doi.org/10.1136/sextrans-2015-052270.209

Keen P; Jamil M; Callander D; Conway DP; McNulty A; Davies SC; Couldwell DL; Smith DE; Holt M; Vaccher SJ; Gray J; Cunningham P; Prestage G; Guy R; Framework OBOTNRHTE, 'Corrigendum to: Rapid HIV testing increases testing frequency among gay and bisexual men: a controlled before–after study', Sexual Health, vol. 16, pp. 299 - 299, http://dx.doi.org/10.1071/sh18161_co

Fraser D; Chan C; Vaccher S; Holt M; Prestage G; Zablotska-Manos I; Grulich A; Bavinton B, 2020, Report on the PrEP in NSW Transition Study, 2018-2020, http://dx.doi.org/10.26190/5ecb122f3a264, http://handle.unsw.edu.au/1959.4/unsworks_67663

Prestage G; Hammoud M; Bavinton B; Bourne A; Holt M; Vaccher S; Degenhardt L; Maher L; Keen P; Haire B; Grulich A; Jin F, 2019, 'ELIGIBILITY FOR AND USE OF HIV PRE-EXPOSURE PROPHYLAXIS AMONG AUSTRALIAN GAY AND BISEXUAL MEN OVER TIME', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 95, pp. A209 - A209, http://dx.doi.org/10.1136/sextrans-2019-sti.527

Vaccher S; Holt M; Prestage G; Amin J; Selvey C; Zablotska-Manos I; Guy R; Jin F; Carr A; Grulich A; Bavinton B, 2019, 'Methamphetamine users in the EPIC-NSW study report high adherence to pre-exposure prophylaxis (PrEP)', Perth, Western Australia, presented at Australian HIV and AIDS Conference, Perth, Western Australia, 17 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/965b72bcb63f490083f4c0b91255431c

Keen P; Hammoud M; Bourne A; Bavinton BR; Vaccher S; Holt M; Grulich A; Saxton P; Jin F; Maher L; Haire B; Prestage G, 2019, 'USE OF HIV PRE-EXPOSURE PROPHYLAXIS (PREP) ASSOCIATED WITH LOWER HIV RELATED ANXIETY AMONG AUSTRALIAN GAY AND BISEXUAL MEN WHO ARE AT HIGH RISK OF HIV INFECTION.', presented at 2019 Joint Australasian Sexual Health and HIV/AIDS Conference, Perth, 16 September 2019 - 19 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/dc3821f54761425c8852c0aa1b57eff8

Vaccher S; Guy R; Templeton D; Zablotska-Manos I; Clackett S; Holt M; Prestage G; Amin J; Selvey C; Jin F; Grulich A; Bavinton B, 2019, 'Pre-exposure prophylaxis use among trans and gender diverse people: Characteristics and behaviour from the EPIC-NSW trial', Vancouver, Canada, presented at STI & HIV World Congress, Vancouver, Canada, 14 July 2019

Bavinton B; Vaccher S; Holt M; Guy R; Prestage G; Jin F; Amin J; Templeton D; Selvey C; Zablotska-Manos I; Lusk J; Ogilvie E; Vickers T; Smith D; Grulich A, 2019, 'USE OF CONDOMS FOR THE PREVENTION OF SEXUALLY TRANSMITTED INFECTIONS (STIS) AMONG HIV PRE-EXPOSURE PROPHYLAXIS (PREP) USERS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 95, pp. A206 - A206, http://dx.doi.org/10.1136/sextrans-2019-sti.521

Vickers T; Patel P; Vaccher S; Watchirs-Smith L; McManus H; Carter A; Asselin J; El-Hayek C; Traeger M; McNulty A; Donovan B; Guy R, 2019, 'JUST ANOTHER TEST: STI TESTING FREQUENCIES OF GAY AND BISEXUAL MEN IN AUSTRALIA', presented at Australasian HIV & AIDS and Sexual Health Conferences, Perth, 16 September 2019 - 19 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/de49984ef1514138b7a4ee6fb1b96d35

Vaccher S; Kolstee J; Holt M; Haire B; Prestage G, 2019, 'The social media response to an Australian PrEP seroconversion', Perth, Western Australia, presented at Australian HIV and AIDS Conference, Perth, Western Australia, 17 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/85842bc72f3443e5a878c2bbb5ea0541

Prestage G; Keen P; Hammoud M; Bourne A; Bavinton B; Holt M; Vaccher S; Saxton P; Maher L; Haire B; Jin F, 2019, 'ANXIETY ABOUT HIV AND USE OF HIV PRE-EXPOSURE PROPHYLAXIS AMONG GAY AND BISEXUAL MEN', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 95, pp. A209 - A210, http://dx.doi.org/10.1136/sextrans-2019-sti.529

Vaccher S, 2019, Adherence to HIV pre-exposure prophylaxis (PrEP) in New South Wales, Australia, http://handle.unsw.edu.au/1959.4/63345

Vaccher S; Grulich A; Haire B; Templeton D; McNulty A; Foster R; Ooi C; Poynten M; Prestage G; Zablotska-Manos I, 2018, 'High adherence to HIV PrEP among clinic attendees over 12 months in the PRELUDE open-label demonstration project', Canberra, Australia, presented at Australian HIV and AIDS Conference, Canberra, Australia, 06 November 2018

Vaccher S; Amin J; Guy R; Jin F; Selvey C; Zablotska-Manos I; Holden J; Price K; Yeung B; Levitt G; Ogilvie E; McNulty A; Smith D; Cooper D; Grulich A, 2018, 'Baseline preferences for daily and non-daily PrEP dosing in EPIC-NSW', in Australasian HIV and AIDS Conference Handbook, Sydney, Australia, presented at Australasian HIV and AIDS Conference, Sydney, Australia, 26 September 2018, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/36f06f6908734ab9a17095cab8705e35

Hammoud MA; Vaccher S; Bourne A; Haire B; Lea T; Jin F; Maher L; Prestage G, 2018, 'The new MTV generation: using methamphetamine, Truvada and Viagra to enhance sex and stay safe', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 21, pp. 114 - 115, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440002700238&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vaccher S; Marzinke M; Grulich AE; Ooi C; Carr A; Haire BG; Selvey C; Templeton DJ; Holt M; Crooks L; Zablotska I, 2017, 'High adherence to HIV pre-exposure prophylaxis (PrEP) in participants presenting for month 12 visit in PRELUDEopen-label study in NSW, Australia', Paris, France, presented at International AIDS Society, Paris, France, 23 July 2017 - 26 July 2017, http://programme.ias2017.org/Abstract/Abstract/3358

Hammoud MA; Vaccher S; Haire BG; Lea T; Maher L; Jin F; Bourne A; Prestage G, 2017, 'The new MTV generation- Using Meth, Truvada, and Viagra to stay safe and enhance sex: Results from the Flux Study', in Australasian HIV/AIDS Conference Handbook, Australasian HIV/AIDS Conference, Canberra, presented at Australasian HIV/AIDS Conference, Canberra, 06 November 2017 - 10 November 2017

Vaccher S; Callander D; Maher L; Zablotska-Manos I; Haire B, 2017, '“Breakfast cereal, glass of orange juice and my PrEP”: A qualitative exploration of adherence and non-adherence to daily pre-exposure prophylaxis (PrEP)', Canberra, Australia, presented at Australian HIV and AIDS Conference, Canberra, Australia, 06 November 2017

Haire BG; Vaccher S; Callander D; Murphy D; Zablotska-Manos I; Maher L; Cook T; Kaldor JM, 2017, '“I Feel That I’m Finally Fully Enjoying Sex For The First Time In My Life”: The Impact Of Prep On Sexual Cultures From The SIN-Prep Study', in HIV/AIDS and and SH Abstracts, Australasian HIV&AIDS Conference, Canberra, presented at Australasian HIV/AIDS Conference, Canberra, 06 November 2017 - 09 November 2017

Vaccher SJ; Grulich A; Prestage G; Bavinton B; Zablotska-Manos I, 2016, 'Use of behavioural eligibility criteria to identify high-HIV risk gay and bisexual men (GBM) for enrolment in a pre-exposure prophylaxis (PrEP) study in NSW, Australia', Durban, South Africa, presented at AIDS 2016, Durban, South Africa, 16 July 2016 - 21 July 2017

Vaccher S; Kannangara D; Baysari M; Zwar N; Reath J; Williams K; Day R, 2015, 'IDENTIFYING BARRIERS TO TREATING GOUT EFFECTIVELY: A QUALITATIVE STUDY OF PATIENTS' AND GENERAL PRACTITIONERS' UNDERSTANDING AND MANAGEMENT OF GOUT', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 14 - 14, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vaccher S; Prestage G; McNulty A; Carr A; Holden J; Schmidt H-M; Holt M; Ooi C; Templeton D; Poynten M; Grulich A; Zablotska-Manos I, 2015, 'Characteristics of Gay Men in Sydney using HIV Pre-Exposure Prophylaxis (PrEP): Baseline Data from the PrELUDE Study', Brisbane, Australia, presented at Australian HIV and AIDS Conference, Brisbane, Australia, 16 September 2015

Vaccher S; Kannangara D; Baysari M; Zwar N; Reath J; Williams K; Day R, 2014, 'Barriers to care in gout: A qualitative study of patients’ and prescribers’ understanding and management', Melbourne, Australia, presented at ASCEPT Scientific Meeting, Melbourne, Australia, 07 December 2014